| Teva Pharma AG - Temozolomid-Teva 250 mg, Kapseln | | 61225 | | 06 | | Temozolomid-Teva 250 mg | | Kapseln | | L01AX03 | | Temozolomide | | 14.10.2010 | | |
| | Composition | | temozolomidum 250 mg, lactosum 209 mg, carboxymethylamylum natricum A corresp. natrium 1.05 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Temozolomide | 250 mg |
| | BAG: Active Agent | Dose |
|---|
| Temozolomide | 250 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Nigrum) | | | | Acidum Stearicum | | | | Tartaric Acid | | | | Ammonii Hydroxidum | | | | Carboxymethylamylum Natricum A | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Lactosum | 209 mg | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 011 | 5 Capsule(s) | 445.02 | 500.40 | A | SL | No |
|
|
